MCID: DRG026
MIFTS: 46

Drug Reaction with Eosinophilia and Systemic Symptoms

Categories: Blood diseases, Immune diseases, Rare diseases, Skin diseases

Aliases & Classifications for Drug Reaction with Eosinophilia and Systemic Symptoms

MalaCards integrated aliases for Drug Reaction with Eosinophilia and Systemic Symptoms:

Name: Drug Reaction with Eosinophilia and Systemic Symptoms 52
Drug Rash with Eosinophilia and Systemic Symptoms 52 58
Drug Reaction Eosinophilic Systemic Syndrome 52 58
Dress Syndrome 52 58

Characteristics:

Orphanet epidemiological data:

58
drug rash with eosinophilia and systemic symptoms
Inheritance: Not applicable; Age of onset: All ages;

Classifications:

Orphanet: 58  
Rare skin diseases
Rare allergic disease


Summaries for Drug Reaction with Eosinophilia and Systemic Symptoms

NIH Rare Diseases : 52 The following summary is from Orphanet , a European reference portal for information on rare diseases and orphan drugs. Orpha Number: 139402 Definition A rare hypersensitivity reaction characterized by a generalized skin rash, fever, eosinophilia, lymphocytosis and visceral involvement (hepatitis, nephritis, pneumonitis, pericarditis and myocarditis) and, in some patients, reactivation of human herpes virus 6. Epidemiology Prevalence is unknown. Etiology Onset usually occurs 2-6 weeks after administration of the causal medication. DRESS syndrome is most frequently associated with anticonvulsants and sulfonamides but other medications (allopurinol, cyclosporine, azathioprine, gold salts and antiviral agents) have also been implicated. The manifestations may persist for several weeks after withdrawal of the causative medication. Visit the Orphanet disease page for more resources.

MalaCards based summary : Drug Reaction with Eosinophilia and Systemic Symptoms, also known as drug rash with eosinophilia and systemic symptoms, is related to exanthem and uveitis. An important gene associated with Drug Reaction with Eosinophilia and Systemic Symptoms is HLA-B (Major Histocompatibility Complex, Class I, B), and among its related pathways/superpathways are Apoptosis and survival Anti-apoptotic TNFs/NF-kB/Bcl-2 pathway and Downstream signaling in naive CD8+ T cells. The drugs tannic acid and Benzocaine have been mentioned in the context of this disorder. Affiliated tissues include skin, lymph node and testes, and related phenotypes are encephalitis and fever

Wikipedia : 74 Drug reaction with eosinophilia and systemic symptoms (DRESS), also termed drug-induced hypersensitivity... more...

Related Diseases for Drug Reaction with Eosinophilia and Systemic Symptoms

Diseases related to Drug Reaction with Eosinophilia and Systemic Symptoms via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 430, show less)
# Related Disease Score Top Affiliating Genes
1 exanthem 31.1 TNF CRP
2 uveitis 30.2 TNF HLA-B
3 graft-versus-host disease 30.1 TNF HLA-B
4 acute cystitis 30.1 TNF CRP
5 pharyngitis 30.0 TNF CRP
6 severe cutaneous adverse reaction 30.0 TNF HLA-B CRP
7 endocarditis 29.9 TNF CRP
8 intermediate uveitis 29.9 TNF HLA-B
9 toxic shock syndrome 29.8 TNF CRP
10 urticaria 29.8 TNF CRP
11 myocarditis 29.8 TNF HLA-B
12 rubella 29.8 TNF HLA-B
13 adult-onset still's disease 29.8 TNF CRP
14 rosacea 29.7 TNF CRP
15 conjunctivitis 29.7 TNF HLA-B
16 alopecia areata 29.7 TNF HLA-B
17 alcoholic hepatitis 29.7 TNF CRP
18 infective endocarditis 29.7 TNF CRP
19 cellulitis 29.7 TNF CRP
20 pericarditis 29.7 TNF CRP
21 pyelonephritis 29.7 TNF CRP
22 purpura 29.7 TNF CRP
23 collagen disease 29.7 TNF CRP
24 lymphadenitis 29.7 TNF CRP
25 familial mediterranean fever 29.7 TNF CRP
26 pulmonary tuberculosis 29.6 TNF CRP
27 kawasaki disease 29.5 TNF CRP
28 viral hepatitis 29.5 TNF CRP
29 meningoencephalitis 29.4 TNF CRP
30 cytomegalovirus infection 29.3 TNF HLA-B
31 cholangitis 29.3 TNF HLA-B CRP
32 autoimmune disease 29.3 TNFRSF4 TNF HLA-B CRP
33 viral pneumonia 29.3 TNF CRP
34 acute pancreatitis 29.3 TNF CRP
35 endophthalmitis 29.3 TNF CRP
36 herpes zoster 29.2 TNF HLA-B CRP
37 vasculitis 29.2 TNF HLA-B CRP
38 hashimoto thyroiditis 29.2 TNF HLA-B CRP
39 obstructive jaundice 29.2 TNF CRP
40 brucellosis 29.2 TNF CRP
41 disseminated intravascular coagulation 29.1 TNF CRP
42 juvenile rheumatoid arthritis 29.0 TNF CRP
43 panuveitis 28.9 TNF HLA-B CRP
44 arthritis 28.9 TNF HLA-B CRP
45 skin disease 28.9 TNF HLA-B CRP
46 iridocyclitis 28.7 TNF HLA-B CRP
47 inflammatory bowel disease 28.7 TNFRSF4 TNF HLA-B CRP
48 rheumatic disease 28.7 TNF HLA-B CRP
49 hypereosinophilic syndrome 11.3
50 allergic hypersensitivity disease 10.9
51 erythema multiforme 10.6
52 stevens-johnson syndrome/toxic epidermal necrolysis 10.5
53 erythema multiforme major 10.5
54 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 10.5
55 thyroiditis 10.4
56 acute kidney failure 10.4
57 vitiligo-associated multiple autoimmune disease susceptibility 6 10.3
58 vitiligo-associated multiple autoimmune disease susceptibility 1 10.3
59 interstitial nephritis 10.3
60 alopecia 10.3
61 diarrhea 10.3
62 thrombocytopenia 10.3
63 hemolytic anemia 10.3
64 47,xyy 10.3
65 acute generalized exanthematous pustulosis 10.3
66 pfeiffer syndrome 10.2
67 anemia, autoimmune hemolytic 10.2
68 myeloma, multiple 10.2
69 vogt-koyanagi-harada disease 10.2
70 graves' disease 10.2
71 pancytopenia 10.2
72 hepatitis a 10.2
73 gout 10.2
74 cholecystitis 10.2
75 kidney disease 10.2
76 hyperthyroidism 10.2
77 myeloid leukemia 10.2
78 acute posterior multifocal placoid pigment epitheliopathy 10.2
79 granulocytopenia 10.2
80 dysphagia 10.2
81 acute liver failure 10.2
82 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.1
83 human immunodeficiency virus type 1 10.1
84 acute kidney tubular necrosis 10.1
85 bipolar i disorder 10.1
86 dermatitis 10.1
87 glomerulonephritis 10.1
88 lymph node tuberculosis 10.1
89 pancreatitis 10.1
90 splenomegaly 10.1
91 tropical spastic paraparesis 10.1 TNFRSF4 HLA-B
92 hepatitis 10.1
93 hypopyon 10.1 HLA-B CRP
94 cardiac arrhythmia 10.0
95 renal cell carcinoma, nonpapillary 10.0
96 myositis 10.0
97 dowling-degos disease 1 10.0
98 rheumatoid arthritis 10.0
99 sturge-weber syndrome 10.0
100 trigeminal neuralgia 10.0
101 vesicoureteral reflux 1 10.0
102 adrenocortical carcinoma, hereditary 10.0
103 alopecia universalis congenita 10.0
104 enterocolitis 10.0
105 immune deficiency disease 10.0
106 sjogren syndrome 10.0
107 graves disease 1 10.0
108 gallbladder disease 1 10.0
109 pars planitis 10.0
110 dermatofibrosarcoma protuberans 10.0
111 kala-azar 1 10.0
112 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.0
113 diabetes mellitus, ketosis-prone 10.0
114 major affective disorder 8 10.0
115 major affective disorder 9 10.0
116 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 10.0
117 adrenal cortical carcinoma 10.0
118 hemophagocytic lymphohistiocytosis 10.0
119 lymphoma 10.0
120 colitis 10.0
121 drug allergy 10.0
122 mucositis 10.0
123 angioimmunoblastic t-cell lymphoma 10.0
124 osteomyelitis 10.0
125 parotitis 10.0
126 sialadenitis 10.0
127 respiratory failure 10.0
128 pseudomembranous conjunctivitis 10.0
129 epidural abscess 10.0
130 esophagitis 10.0
131 neutropenia 10.0
132 hepatic coma 10.0
133 dilated cardiomyopathy 10.0
134 hepatic encephalopathy 10.0
135 cholestasis 10.0
136 facial paralysis 10.0
137 hypothyroidism 10.0
138 angioedema 10.0
139 hyperuricemia 10.0
140 autoimmune hepatitis 10.0
141 post-traumatic stress disorder 10.0
142 thrombocytosis 10.0
143 polyclonal hypergammaglobulinemia 10.0
144 basal cell carcinoma 10.0
145 acalculous cholecystitis 10.0
146 anuria 10.0
147 astrocytoma 10.0
148 bipolar disorder 10.0
149 lactic acidosis 10.0
150 insulinoma 10.0
151 adrenal cortical adenocarcinoma 10.0
152 systemic scleroderma 10.0
153 spongiotic dermatitis 10.0
154 folliculitis 10.0
155 schizoaffective disorder 10.0
156 pneumonia 10.0
157 congestive heart failure 10.0
158 acute stress disorder 10.0
159 lymphopenia 10.0
160 herpes simplex 10.0
161 leishmaniasis 10.0
162 pompholyx 10.0
163 encephalitis 10.0
164 toxoplasmosis 10.0
165 cytokine deficiency 10.0
166 eosinophilic pustular folliculitis 10.0
167 exfoliative dermatitis 10.0
168 pure autonomic failure 10.0
169 virus associated hemophagocytic syndrome 10.0
170 weber syndrome 10.0
171 encephalopathy 10.0
172 postherpetic neuralgia 10.0
173 seizure disorder 10.0
174 hemophagocytic syndrome associated with an infection 10.0
175 low-grade astrocytoma 10.0
176 cutaneous pseudolymphoma 10.0
177 nodular goiter 10.0 TNFRSF4 CRP
178 cardiac arrest 10.0
179 spondyloarthropathy 9.9 TNF HLA-B
180 nontuberculous mycobacterial lung disease 9.9 TNF HLA-B
181 alveolar echinococcosis 9.9 TNF HLA-B
182 acute graft versus host disease 9.9 TNFRSF4 TNF
183 echinococcosis 9.9 TNF HLA-B
184 cytomegalovirus retinitis 9.9 TNF HLA-B
185 autoimmune gastritis 9.9 TNF HLA-B
186 histoplasmosis 9.9 TNF HLA-B
187 lambert-eaton myasthenic syndrome 9.9 TNF HLA-B
188 aphthous stomatitis 9.9 TNF HLA-B
189 dengue hemorrhagic fever 9.8 TNF HLA-B
190 rheumatoid arthritis interstitial lung disease 9.8 TNF CRP
191 posterior scleritis 9.8 TNF CRP
192 scleritis 9.8 TNF CRP
193 louse-borne relapsing fever 9.8 TNF CRP
194 relapsing fever 9.8 TNF CRP
195 opportunistic bacterial infectious disease 9.8 TNF CRP
196 gastrointestinal tuberculosis 9.8 TNF CRP
197 intestinal tuberculosis 9.8 TNF CRP
198 nocardiosis 9.8 TNF CRP
199 neurosarcoidosis 9.8 TNF CRP
200 gastroduodenal crohn's disease 9.8 TNF CRP
201 cardiac rupture 9.8 TNF CRP
202 aortitis 9.8 TNF CRP
203 tuberculous epididymitis 9.8 TNF CRP
204 osteoporosis 9.8
205 ascites, chylous 9.8
206 bone mineral density quantitative trait locus 8 9.8
207 bone mineral density quantitative trait locus 15 9.8
208 hydrops, lactic acidosis, and sideroblastic anemia 9.8
209 mental depression 9.8
210 cheilitis 9.8
211 hepatitis c 9.8
212 agammaglobulinemia 9.8
213 bilirubin metabolic disorder 9.8
214 liver cirrhosis 9.8
215 septic arthritis 9.8
216 influenza 9.8
217 tuberculous meningitis 9.8
218 depression 9.8
219 abdominal tuberculosis 9.8 TNF CRP
220 heart aneurysm 9.8 TNF CRP
221 tenosynovitis 9.8 TNF CRP
222 synovitis 9.8 TNF CRP
223 coronary aneurysm 9.8 TNF CRP
224 chondromalacia 9.8 TNF CRP
225 toxic megacolon 9.8 TNF CRP
226 scleral disease 9.8 TNF CRP
227 lung abscess 9.8 TNF CRP
228 bursitis 9.8 TNF CRP
229 good syndrome 9.8 TNF CRP
230 chlamydia pneumonia 9.8 TNF CRP
231 chlamydia 9.8 TNF CRP
232 scarlet fever 9.8 TNF CRP
233 salpingitis 9.8 TNF CRP
234 cryptogenic organizing pneumonia 9.8 TNF CRP
235 miliary tuberculosis 9.8 TNF CRP
236 enthesopathy 9.8 TNF CRP
237 laryngitis 9.8 TNF CRP
238 central nervous system vasculitis 9.8 TNF CRP
239 paratyphoid fever 9.8 TNF CRP
240 typhoid fever 9.8 TNF CRP
241 melancholia 9.8 TNF CRP
242 orchitis 9.8 TNF CRP
243 acute proliferative glomerulonephritis 9.8 TNF CRP
244 mononeuropathy 9.8 TNF CRP
245 hantavirus hemorrhagic fever with renal syndrome 9.8 TNF CRP
246 tendinitis 9.8 TNF CRP
247 polyradiculopathy 9.8 TNF CRP
248 urethritis 9.8 TNF CRP
249 nasopharyngitis 9.8 TNF CRP
250 hypersensitivity reaction type iii disease 9.8 TNF CRP
251 blood group, globoside system 9.8 TNF CRP
252 decubitus ulcer 9.8 TNF CRP
253 subacute thyroiditis 9.8 TNF CRP
254 cartilage disease 9.8 TNF CRP
255 erysipelas 9.8 TNF CRP
256 meconium aspiration syndrome 9.8 TNF CRP
257 primary systemic mycosis 9.8 TNF CRP
258 pneumocystosis 9.8 TNF CRP
259 chronic recurrent multifocal osteomyelitis 9.8 TNF CRP
260 compartment syndrome 9.8 TNF CRP
261 cecal disease 9.8 TNF CRP
262 bronchopneumonia 9.8 TNF CRP
263 fallopian tube disease 9.8 TNF CRP
264 pyelitis 9.8 TNF CRP
265 streptococcus pneumonia 9.8 TNF CRP
266 danubian endemic familial nephropathy 9.8 TNF CRP
267 ischemic bone disease 9.8 TNF CRP
268 chronic ulcer of skin 9.8 TNF CRP
269 gingival disease 9.8 TNF CRP
270 pericardium disease 9.8 TNF CRP
271 chickenpox 9.8 TNF CRP
272 perinatal necrotizing enterocolitis 9.8 TNF CRP
273 diverticulitis 9.8 TNF CRP
274 splenic disease 9.8 TNF CRP
275 mycoplasma pneumoniae pneumonia 9.8 TNF CRP
276 vaginal disease 9.8 TNF CRP
277 scrub typhus 9.8 TNF CRP
278 sebaceous gland disease 9.8 TNF CRP
279 endocardium disease 9.8 TNF CRP
280 middle ear disease 9.8 TNF CRP
281 proctitis 9.8 TNF CRP
282 hepatic vascular disease 9.8 TNF CRP
283 apnea, obstructive sleep 9.8 TNF CRP
284 conjunctival disease 9.8 TNF CRP
285 coccidiosis 9.8 TNF CRP
286 dysentery 9.8 TNF CRP
287 sclerosing cholangitis 9.8 TNF HLA-B
288 anus disease 9.8 TNF CRP
289 extrapulmonary tuberculosis 9.8 TNF CRP
290 pyoderma 9.8 TNF CRP
291 rectal disease 9.8 TNF CRP
292 prediabetes syndrome 9.8 TNF CRP
293 lymphoid interstitial pneumonia 9.8 TNF CRP
294 leptospirosis 9.8 TNF CRP
295 pleurisy 9.8 TNF CRP
296 bacterial sepsis 9.8 TNF CRP
297 opportunistic mycosis 9.8 TNF CRP
298 endocrine pancreas disease 9.8 TNF CRP
299 paranasal sinus disease 9.8 TNF CRP
300 ankylosis 9.8 TNF CRP
301 preterm premature rupture of the membranes 9.8 TNF CRP
302 lymph node disease 9.8 TNF CRP
303 systolic heart failure 9.8 TNF CRP
304 nose disease 9.8 TNF CRP
305 cystitis 9.8 TNF CRP
306 vein disease 9.8 TNF CRP
307 appendicitis 9.8 TNF CRP
308 extrinsic cardiomyopathy 9.8 TNF CRP
309 hypersensitivity reaction type iv disease 9.8 TNF CRP
310 commensal bacterial infectious disease 9.8 TNF CRP
311 carotid stenosis 9.8 TNF CRP
312 bronchiolitis obliterans 9.8 TNF CRP
313 bronchiolitis 9.8 TNF CRP
314 severe acute respiratory syndrome 9.8 TNF CRP
315 pleural disease 9.8 TNF CRP
316 filariasis 9.8 TNF CRP
317 temporal arteritis 9.8 TNF CRP
318 sleep disorder 9.8 TNF CRP
319 ileus 9.8 TNF CRP
320 peripheral artery disease 9.8 TNF CRP
321 chorioamnionitis 9.8 TNF CRP
322 bacterial meningitis 9.8 TNF CRP
323 iron deficiency anemia 9.7 TNF CRP
324 visceral leishmaniasis 9.7 TNF CRP
325 fabry disease 9.7 TNF CRP
326 bacterial pneumonia 9.7 TNF CRP
327 lyme disease 9.7 TNF CRP
328 proteasome-associated autoinflammatory syndrome 1 9.7 TNF CRP
329 retinal vascular disease 9.7 TNF CRP
330 blood coagulation disease 9.7 TNF CRP
331 bone resorption disease 9.7 TNF CRP
332 exudative vitreoretinopathy 1 9.7 TNF CRP
333 antiphospholipid syndrome 9.7 TNF CRP
334 pulmonary edema 9.7 TNF CRP
335 placenta disease 9.7 TNF CRP
336 lymphatic system disease 9.7 TNF CRP
337 bone remodeling disease 9.7 TNF CRP
338 leptin deficiency or dysfunction 9.7 TNF CRP
339 fibromyalgia 9.7 TNF CRP
340 plasmodium falciparum malaria 9.7 TNF CRP
341 parasitic protozoa infectious disease 9.7 TNF CRP
342 intracranial berry aneurysm 9.7 TNF CRP
343 sleep apnea 9.7 TNF CRP
344 autoimmune disease of musculoskeletal system 9.7 TNF CRP
345 colorectal adenoma 9.7 TNF CRP
346 neurofibromatosis, type ii 9.7
347 cardiac conduction defect 9.7
348 fibrosis of extraocular muscles, congenital, 1 9.7
349 hypertension, essential 9.7
350 systemic lupus erythematosus 9.7
351 noonan syndrome 1 9.7
352 cystic fibrosis 9.7
353 ocular motor apraxia 9.7
354 gastrointestinal stromal tumor 9.7
355 major depressive disorder 9.7
356 hepatitis c virus 9.7
357 intraocular pressure quantitative trait locus 9.7
358 chorea, childhood-onset, with psychomotor retardation 9.7
359 metabolic acidosis 9.7
360 thrombosis 9.7
361 endometritis 9.7
362 pleural tuberculosis 9.7
363 thrombotic thrombocytopenic purpura 9.7
364 intracranial aneurysm 9.7
365 myopia 9.7
366 paranoid schizophrenia 9.7
367 choreatic disease 9.7
368 alcoholic liver cirrhosis 9.7
369 pyuria 9.7
370 status epilepticus 9.7
371 focal epilepsy 9.7
372 syphilis 9.7
373 hyperglycemia 9.7
374 erdheim-chester disease 9.7
375 pustulosis of palm and sole 9.7
376 peripheral nervous system disease 9.7
377 eosinophilic pneumonia 9.7
378 chronic kidney disease 9.7
379 neuropathy 9.7
380 chorioretinitis 9.7
381 psoriasis 9.7
382 autoimmune enteropathy 9.7
383 limbic encephalitis 9.7
384 lymphangiomatosis 9.7
385 ocular toxoplasmosis 9.7
386 polymyositis 9.7
387 prosthetic joint infection 9.7
388 pseudo-turner syndrome 9.7
389 pustular psoriasis 9.7
390 raynaud phenomenon 9.7
391 chronic pain 9.7
392 diffuse alveolar hemorrhage 9.7
393 cardiogenic shock 9.7
394 severe immune-mediated enteropathy 9.7
395 thrombotic microangiopathy 9.7
396 uremia 9.7 TNF CRP
397 vascular dementia 9.7 TNF CRP
398 gastroenteritis 9.7 TNF CRP
399 bronchial disease 9.7 TNF CRP
400 bronchiectasis 9.7 TNF CRP
401 otitis media 9.7 TNF CRP
402 primary bacterial infectious disease 9.6 TNF CRP
403 periodontitis 9.6 TNF CRP
404 bile duct disease 9.6 TNF CRP
405 bronchitis 9.6 TNF CRP
406 granulomatosis with polyangiitis 9.6 TNF CRP
407 biliary tract disease 9.6 TNF CRP
408 peritonitis 9.6 TNF CRP
409 muscle tissue disease 9.6 TNF CRP
410 optic nerve disease 9.6 TNF CRP
411 bone inflammation disease 9.5 TNF CRP
412 blood platelet disease 9.5 TNF CRP
413 myasthenia gravis 9.5 TNFRSF4 TNF HLA-B
414 iritis 9.5 TNF HLA-B CRP
415 spondylitis 9.4 TNF HLA-B CRP
416 uveal disease 9.4 TNF HLA-B CRP
417 reactive arthritis 9.4 TNF HLA-B CRP
418 takayasu arteritis 9.4 TNF HLA-B CRP
419 spondyloarthropathy 1 9.4 TNF HLA-B CRP
420 arthropathy 9.4 TNF HLA-B CRP
421 meningitis 9.4 TNF HLA-B CRP
422 acquired immunodeficiency syndrome 9.4 TNF HLA-B CRP
423 psoriatic arthritis 9.4 TNF HLA-B CRP
424 behcet syndrome 9.4 TNF HLA-B CRP
425 celiac disease 1 9.4 TNF HLA-B CRP
426 deficiency anemia 9.4 TNF HLA-B CRP
427 diabetes mellitus, insulin-dependent 9.4 TNF HLA-B CRP
428 inherited metabolic disorder 9.4 TNF CRP
429 gestational diabetes 9.3 TNF CRP
430 upper respiratory tract disease 9.2 TNF CRP

Graphical network of the top 20 diseases related to Drug Reaction with Eosinophilia and Systemic Symptoms:



Diseases related to Drug Reaction with Eosinophilia and Systemic Symptoms

Symptoms & Phenotypes for Drug Reaction with Eosinophilia and Systemic Symptoms

Human phenotypes related to Drug Reaction with Eosinophilia and Systemic Symptoms:

58 31 (showing 28, show less)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 encephalitis 58 31 hallmark (90%) Very frequent (99-80%) HP:0002383
2 fever 58 31 hallmark (90%) Very frequent (99-80%) HP:0001945
3 skin rash 58 31 hallmark (90%) Very frequent (99-80%) HP:0000988
4 erythema 58 31 hallmark (90%) Very frequent (99-80%) HP:0010783
5 macule 58 31 hallmark (90%) Very frequent (99-80%) HP:0012733
6 weight loss 58 31 hallmark (90%) Very frequent (99-80%) HP:0001824
7 thyroiditis 58 31 hallmark (90%) Very frequent (99-80%) HP:0100646
8 lymphadenopathy 58 31 hallmark (90%) Very frequent (99-80%) HP:0002716
9 erythroderma 58 31 hallmark (90%) Very frequent (99-80%) HP:0001019
10 cardiac arrest 58 31 hallmark (90%) Very frequent (99-80%) HP:0001695
11 immunologic hypersensitivity 58 31 hallmark (90%) Very frequent (99-80%) HP:0100326
12 angioedema 58 31 hallmark (90%) Very frequent (99-80%) HP:0100665
13 pulmonary infiltrates 58 31 frequent (33%) Frequent (79-30%) HP:0002113
14 elevated hepatic transaminase 58 31 frequent (33%) Frequent (79-30%) HP:0002910
15 lymphocytosis 58 31 frequent (33%) Frequent (79-30%) HP:0100827
16 interstitial pneumonitis 58 31 frequent (33%) Frequent (79-30%) HP:0006515
17 renal insufficiency 58 31 occasional (7.5%) Occasional (29-5%) HP:0000083
18 dyspnea 58 31 occasional (7.5%) Occasional (29-5%) HP:0002094
19 hepatitis 58 31 occasional (7.5%) Occasional (29-5%) HP:0012115
20 peripheral neuropathy 58 31 occasional (7.5%) Occasional (29-5%) HP:0009830
21 cough 58 31 occasional (7.5%) Occasional (29-5%) HP:0012735
22 nephrotic syndrome 58 31 occasional (7.5%) Occasional (29-5%) HP:0000100
23 myocarditis 58 31 occasional (7.5%) Occasional (29-5%) HP:0012819
24 acute hepatic failure 58 31 occasional (7.5%) Occasional (29-5%) HP:0006554
25 eosinophilia 58 31 occasional (7.5%) Occasional (29-5%) HP:0001880
26 tubulointerstitial nephritis 58 31 occasional (7.5%) Occasional (29-5%) HP:0001970
27 pustule 58 31 occasional (7.5%) Occasional (29-5%) HP:0200039
28 enanthema 58 31 occasional (7.5%) Occasional (29-5%) HP:0030249

Drugs & Therapeutics for Drug Reaction with Eosinophilia and Systemic Symptoms

Drugs for Drug Reaction with Eosinophilia and Systemic Symptoms (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 41, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
tannic acid Approved Phase 2, Phase 3 1401-55-4
2
Benzocaine Approved, Investigational Phase 2, Phase 3 94-09-7, 1994-09-7 2337
3
Maraviroc Approved, Investigational Phase 2, Phase 3 376348-65-1 3002977
4 Anti-Infective Agents Phase 2, Phase 3
5 Anti-Retroviral Agents Phase 2, Phase 3
6 Anti-HIV Agents Phase 2, Phase 3
7 Antiviral Agents Phase 2, Phase 3
8 Immunoglobulins Phase 3
9 Antibodies Phase 3
10
Prednisone Approved, Vet_approved 53-03-2 5865
11
Clobetasol Approved, Experimental, Investigational 25122-46-7, 25122-41-2 32798 5311051
12
Methylprednisolone Approved, Vet_approved 83-43-2 6741
13
Methylprednisolone hemisuccinate Approved 2921-57-5
14
Prednisolone Approved, Vet_approved 50-24-8 5755
15
Etanercept Approved, Investigational 185243-69-0
16 Prednisolone acetate Approved, Vet_approved 52-21-1
17
Prednisolone phosphate Approved, Vet_approved 302-25-0
18
Eslicarbazepine acetate Approved 75970-99-9, 236395-14-5 123618
19
Prednisolone hemisuccinate Experimental 2920-86-7
20 Dermatologic Agents
21 Emollients
22 Anti-Inflammatory Agents
23 glucocorticoids
24 Antineoplastic Agents, Hormonal
25 Hormone Antagonists
26 Hormones
27 Immunosuppressive Agents
28 Gastrointestinal Agents
29 Methylprednisolone Acetate
30 Immunologic Factors
31 Protective Agents
32 Neuroprotective Agents
33 Analgesics, Non-Narcotic
34 Antiemetics
35 Analgesics
36 Autonomic Agents
37 Anti-Inflammatory Agents, Non-Steroidal
38 Antirheumatic Agents
39 Anticonvulsants
40 Sodium Channel Blockers
41 Diuretics, Potassium Sparing

Interventional clinical trials:

(showing 6, show less)
# Name Status NCT ID Phase Drugs
1 Maraviroc to Augment Rehabilitation Outcomes After Stroke Recruiting NCT03172026 Phase 2, Phase 3 Maraviroc 300 mg;Placebo 300 mg
2 Treatment of DRESS (Drug Reaction With Eosinophilia and Systemic Symptoms) With Tegeline® Terminated NCT00505648 Phase 3 Tegeline®
3 DRESS - Setting of Corticosteroid Treatment. Unknown status NCT01987076 Prednisone;Clobetasol
4 Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions (SCAR) Completed NCT01276314 anti- TNF-a;Prednisolone
5 The Multicenter Registry of Patients With Severe Cutaneous Adverse Reactions Among Tertiary Medical Institutes in Thailand Recruiting NCT02574988
6 An Exploratory Case-Control Study of Genetic and Clinical Factors for Serious Cutaneous Reactions Among Users of Eslicarbazepine Acetate Recruiting NCT02520557

Search NIH Clinical Center for Drug Reaction with Eosinophilia and Systemic Symptoms

Genetic Tests for Drug Reaction with Eosinophilia and Systemic Symptoms

Anatomical Context for Drug Reaction with Eosinophilia and Systemic Symptoms

MalaCards organs/tissues related to Drug Reaction with Eosinophilia and Systemic Symptoms:

40
Skin, Lymph Node, Testes, Liver, T Cells, Thyroid, Kidney

Publications for Drug Reaction with Eosinophilia and Systemic Symptoms

Articles related to Drug Reaction with Eosinophilia and Systemic Symptoms:

(showing 534, show less)
# Title Authors PMID Year
1
Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial. 61
31734103 2020
2
The role of drug, dose and the tolerance/intolerance of new drugs in multiple drug hypersensitivity syndrome (MDH). 61
31814130 2019
3
Facial paralysis associated with drug reaction with eosinophilia and systemic symptoms (DRESS) with oxcarbazepine and reactivation of human herpesvirus 6 (HHV-6). 61
31840232 2019
4
Late-onset interstitial nephritis in a patient with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. 61
31840853 2019
5
Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy. 61
31848905 2019
6
[Acute renal failure secondary to DRESS syndrome]. 61
31830393 2019
7
Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature. 61
31691347 2019
8
Drug reaction with eosinophilia and systemic symptoms: Pediatric case series and literature review. 61
31423638 2019
9
Unique Clinical Characteristics and Prognosis of Allopurinol-Induced Severe Cutaneous Adverse Reactions. 61
31201937 2019
10
HLA-B*58:01 Genotyping to Prevent Cases of DRESS and SJS/TEN in East Asians Treated with Allopurinol-A Canadian Missed Opportunity [Formula: see text]. 61
31378082 2019
11
Drug allergy. 61
31690398 2019
12
Role of in vivo and in vitro tests in the diagnosis of severe cutaneous adverse reactions (SCAR) to drug. 61
31696801 2019
13
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System. 61
31387950 2019
14
An update on the management of severe cutaneous drug hypersensitivity reactions. 61
31692425 2019
15
Drug-Induced liver injury associated with severe cutaneous hypersensitivity reactions. A complex entity in need of a multidisciplinary approach. 61
31696806 2019
16
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms or non-drug-related erythroderma with a persistent human herpesvirus 6 infection. 61
31696531 2019
17
Aplastic anaemia following carbamazepine-induced drug reaction with eosinophilia and systemic symptoms syndrome. 61
31713339 2019
18
Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Related to Aripiprazole Therapy. 61
31688404 2019
19
A case of DRESS (drug reaction with eosinophilia and systemic symptoms) under treatment with eslicarbazepine. 61
31541846 2019
20
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome caused by first-line antituberculosis drugs: Two case reports and a review of the literature. 61
31021423 2019
21
Haplotype analysis in a 16-year-old boy with vancomycin-induced DRESS syndrome. 61
31497897 2019
22
Drug reaction with eosinophilia and systemic symptoms in pediatric patients: A clinicopathological study of 16 cases in the National Center of Pharmacovigilance of Tunisia. 61
31023620 2019
23
Drug reaction with eosinophilia and systemic symptoms and cytomegalovirus colitis. 61
31376489 2019
24
Mepolizumab rescue therapy for acute pneumonitis secondary to DRESS. 61
31604720 2019
25
Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: A 9-year experience in a tertiary care paediatric hospital setting. 61
31608511 2019
26
Severe meningo-/encephalitis after daclizumab therapy for multiple sclerosis. 61
30657420 2019
27
Drug reaction with eosinophilia and systemic symptoms syndrome in a patient taking lamotrigine. 61
31653619 2019
28
Drug reaction with eosinophilia and systemic symptoms in a child with N-methyl-d-aspartate receptor encephalitis. 61
31656436 2019
29
Severe Cutaneous Adverse Reactions to Antiepileptic Drugs: A Nationwide Registry-Based Study in Korea. 61
31332981 2019
30
Vancomycin induced DRESS syndrome (drug reaction with eosinophilia and systemic symptoms) in a patient with tricuspid endocarditis. 61
31527200 2019
31
Sulfonamide Hypersensitivity: Fact and Fiction. 61
31495421 2019
32
Pazopanib-Associated Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome: A Case Report. 61
30946042 2019
33
Reverse Isotopic Phenomenon in Drug Reaction with Eosinophilia and Systemic Symptoms. 61
30236950 2019
34
Can we allow a further intake of drugs poorly suspected as responsible in drug reaction with eosinophilia and systemic symptoms? A study of practice. 61
31313394 2019
35
A Rapid Allele-Specific Assay for HLA-A*32:01 to Identify Patients at Risk for Vancomycin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms. 61
31158526 2019
36
High and variable population prevalence of HLA-B*56:02 in indigenous Australians and relation to phenytoin-associated drug reaction with eosinophilia and systemic symptoms. 61
31206740 2019
37
Drug reaction with eosinophilia and systemic symptoms (DRESS) may occur within two weeks of drug exposure: a retrospective study. 61
31562941 2019
38
Drug reaction with eosinophilia and systemic symptoms presenting as leukoencephalopathy. 61
30868617 2019
39
Making a diagnosis in severe cutaneous drug hypersensitivity reactions. 61
31247634 2019
40
Mechanisms of Severe Cutaneous Adverse Reactions: Recent Advances. 61
31020549 2019
41
Increased Type 2 Innate Lymphoid Cells in Patients with Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome. 61
30735685 2019
42
A rare and severe cutaneous adverse effect of telaprevir: drug rash with eosinophilia and systemic symptoms. 61
31251007 2019
43
DRESS Syndrome Secondary to Carbamazepine Therapy Presenting with Bilateral Acute Anterior Uveitis and Angle Closure Glaucoma. 61
31660117 2019
44
Ethosuximide-induced drug reaction with eosinophilia and systemic symptoms with mediastinal lymphadenopathy. 61
31132165 2019
45
Serum and blister-fluid elevation and decreased epidermal content of high-mobility group box 1 protein in drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. 61
30613954 2019
46
Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019. 61
31000444 2019
47
Severe acute hepatitis in drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome resolved following cyclosporine. 61
31271919 2019
48
Vancomycin-associated drug-induced hypersensitivity syndrome. 61
30738120 2019
49
HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms. 61
30776417 2019
50
Drug reaction with eosinophilia and systemic symptoms syndrome after total knee arthroplasty infection and placement of antibiotic spacer. 61
31286034 2019
51
Can we allow a further intake of drugs poorly suspected as responsible in drug reaction with eosinophilia and systemic symptoms (DRESS)? A study of practice. 61
30834582 2019
52
Comment on "Abnormal erythrocyte morphology in drug reaction with eosinophilia and systemic symptoms". 61
30685268 2019
53
Reply to: "Comment on 'Abnormal erythrocyte morphology in drug reaction with eosinophilia and systemic symptoms'". 61
30685269 2019
54
A Case Report of Fulminant Type 1 Diabetes Mellitus Caused by Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Complicated by Iodine-Induced Thyrotoxicosis. 61
30937841 2019
55
Variation of clinical manifestations according to culprit drugs in DRESS syndrome. 61
31044478 2019
56
HLA-associated antiepileptic drug-induced cutaneous adverse reactions. 61
30895730 2019
57
A Fatal Case of Vancomycin Associated Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome in a Septuagenarian. 61
31497445 2019
58
Drug reaction with eosinophilia and systemic symptoms in a cohort of Asian children. 61
30920020 2019
59
Drug-induced liver injury with skin reactions: Drugs and host risk factors, clinical phenotypes and prognosis. 61
30515930 2019
60
Sorafenib Toxicity Mimicking Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome 61
31141856 2019
61
Predictors of disease severity in drug reaction with eosinophilia and systemic symptoms. 61
30058562 2019
62
Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS Syndrome). 61
30879852 2019
63
Facial pustules due to drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms may histopathologically mimic eosinophilic pustular folliculitis: A case report. 61
30666704 2019
64
DRESS Syndrome. 61
31299851 2019
65
Successful Phenobarbital Desensitization After DRESS Reaction in the Management of Refractory Status Epilepticus. 61
29390946 2019
66
Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS): How Far Have We Come? 61
30652265 2019
67
Abnormal erythrocyte morphology in drug reaction with eosinophilia and systemic symptoms. 61
30403959 2019
68
Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome (DRESS/DIHS) caused by levofloxacin in a patient with systemic scleroderma, rheumatoid arthritis, and Sjogren syndrome. 61
30484869 2019
69
DRESS syndrome associated with influenza virus. 61
31191153 2019
70
[Lamotrigine induced hypersensitivity syndrome in children: a case report]. 61
30996382 2019
71
Phenotypes of Severe Cutaneous Adverse Reactions Caused by Nonsteroidal Anti-inflammatory Drugs. 61
30661313 2019
72
Severe Cutaneous Adverse Reactions in Korean Pediatric Patients: A Study From the Korea SCAR Registry. 61
30661316 2019
73
Oxacillin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). 61
30877266 2019
74
A Rare Case of DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) Syndrome with Cholecystitis in a Patient on Levetiracetam. 61
31131168 2019
75
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs. 61
30663091 2019
76
A Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Associated With Clobazam. 61
30870346 2019
77
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease. 61
30240780 2019
78
Valaciclovir: a culprit drug for drug reaction with eosinophilia and systemic symptoms not to be neglected. Three cases. 61
30222854 2019
79
Clozapine-Induced DRESS Syndrome: A Case Series From the AMSP Multicenter Drug Safety Surveillance Project. 61
29554696 2019
80
Drug reaction with eosinophilia and systemic symptoms syndrome induced by combination of vemurafenib and cobimetinib in melanoma: A series of 11 cases. 61
30081108 2019
81
Efficacy and tolerability of desensitization in the treatment of delayed drug hypersensitivities to anti-tuberculosis medications. 61
30704698 2019
82
Pustular DRESS Syndrome Secondary to Hydroxychloroquine With EBV Reactivation 61
30811149 2019
83
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Identified in the Electronic Health Record Allergy Module. 61
30176295 2019
84
Analysis of Individual Case Safety Reports of Severe Cutaneous Adverse Reactions in Korea. 61
30666843 2019
85
Hypersensitivity Reactions in Serious Adverse Events Reported for Paracetamol in the EudraVigilance Database, 2007⁻2018. 61
30658389 2019
86
Controversies in drug allergy: Testing for delayed reactions. 61
30573342 2019
87
Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Summarized Overview. 61
30058498 2019
88
Fulminant Type 1 Diabetes Mellitus Caused by Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): A Case Report and Review of the Literature. 61
31379742 2019
89
Case Reports of DRESS Syndrome and Symptoms Consistent with DRESS Syndrome Following Treatment with Recently Marketed Monoclonal Antibodies. 61
31308976 2019
90
Vancomycin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Masquerading as Elusive Sepsis. 61
31093389 2019
91
A Unique Case Of Tenofovir-Induced DRESS Syndrome Associated With Raynaud's Of The Tongue. 61
31695475 2019
92
Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series. 61
30621779 2019
93
Carbamazepine-induced DRESS syndrome leading to reversible myocarditis in a child. 61
31114444 2019
94
Direct costs of severe cutaneous adverse reactions in a tertiary hospital in Korea. 61
29466850 2019
95
Drug reaction with eosinophilia and systemic symptoms (DRESS) in children. 61
30830064 2019
96
Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Associated with Ethambutol use: A Case Report. 61
30848209 2019
97
Erythema Gyratum Repens as a Manifestation of Drug Reaction with Eosinophilia and Systemic Symptoms. 61
30745644 2019
98
Co-Occurrence of Multiple Endocrine Abnormalities Induced by the DIHS/DRESS. 61
31687021 2019
99
Pulmonary Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review. 61
31662996 2019
100
Reviewing the Mechanistic Evidence Assessors E-Synthesis and EBM+: A Case Study of Amoxicillin and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). 61
31264541 2019
101
Vancomycin-induced DRESS syndrome treated with systemic steroids in a 16-year-old male. 61
31057800 2019
102
Paediatric case series of drug reaction with eosinophilia and systemic symptoms (DRESS): 12-year experience at a single referral centre in Hong Kong and the first reported use of infliximab. 61
29384118 2018
103
Monocytes are involved in the balance between regulatory T cells and Th17 cells in severe drug eruptions. 61
30112775 2018
104
Trimethoprim-sulfamethoxazole-induced drug reaction with eosinophilia and systemic symptoms in a child with congenital renal disease. 61
30187970 2018
105
Relapsing Course of Sulfasalazine-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Complicated by Alopecia Universalis and Vitiligo. 61
30578426 2018
106
Drug reaction with eosinophilia and systemic symptoms (DRESS) and multiple organ dysfunction syndrome (MODS): one more reason for a new effective treatment against leishmaniasis. 61
30156263 2018
107
High-risk drug rashes. 61
29803714 2018
108
Imatinib-induced drug reaction with eosinophilia and systemic symptoms in solid tumors: a patient with dermatofibrosarcoma protuberans and successful desensitization management. 61
30096127 2018
109
Severe skin toxicity with organ damage under the combination of targeted therapy following immunotherapy in metastatic melanoma. 61
29985833 2018
110
Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome. 61
30368475 2018
111
Prevalence, risk factors, and mortality outcome in the drug reaction with eosinophilia and systemic symptoms patients with cardiac involvement. 61
30099742 2018
112
Cyclosporine treatment of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report and brief review of the literature. 61
30574026 2018
113
A case of Vogt-Koyanagi-Harada disease as a sequela of drug reaction with eosinophilia and systemic symptoms. 61
30306111 2018
114
Drug reaction with eosinophilia and systemic symptoms caused by spironolactone: Case report. 61
30009386 2018
115
Case of drug reaction with eosinophilia and systemic symptoms secondary to vancomycin. 61
30301733 2018
116
Successful treatment of drug reaction with eosinophilia and systemic symptoms syndrome relapse with oral pulsed dexamethasone. 61
30364766 2018
117
Valproate-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). 61
30581223 2018
118
DRESS syndrome-associated acute necrotizing eosinophilic myocarditis with giant cells. 61
30301732 2018
119
Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS. 61
30027105 2018
120
Dolutegravir as a trigger for DRESS syndrome? 61
29621952 2018
121
DRESS syndrome due to vemurafenib treatment: switching BRAF inhibitor to solve a big problem. 61
30275021 2018
122
Myocarditis Associated with Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Case Report and Review of the Literature. 61
30122752 2018
123
Measles during arbovirus outbreak: a diagnostic challenge. 61
30323934 2018
124
Reticular rash in drug reaction with eosinophilia and systemic symptoms syndrome: A clue to parvovirus B19 reactivation? 61
30167447 2018
125
DRESS syndrome: a detailed insight. 61
29519170 2018
126
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in two young children: the importance of an early diagnosis. 61
30111350 2018
127
Antituberculosis Drug-Associated DRESS: A Case Series. 61
29274824 2018
128
Ivermectin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. 61
30023418 2018
129
The Function of HLA-B*13:01 Involved in the Pathomechanism of Dapsone-Induced Severe Cutaneous Adverse Reactions. 61
29458119 2018
130
Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy. 61
29934423 2018
131
Allopurinol-induced DRESS syndrome presented as a cholecystitis-like acute abdomen and aggravated by antibiotics. 61
30042109 2018
132
Successful Intravenous Immunoglobulin Treatment in Pediatric Severe DRESS Syndrome. 61
29198698 2018
133
A Rare Case of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Glimepiride, the Unlikely Culprit. 61
30069245 2018
134
[Drug reaction with eosinophilia and systemic symptoms due to carbamazepine. Pediatric case]. 61
29756718 2018
135
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome due to ethambutol. 61
29602678 2018
136
Drug reaction with eosinophilia and systemic symptoms: DRESS syndrome. 61
29687681 2018
137
Serum thymus and activation-regulated chemokine is associated with the severity of drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome. 61
29150836 2018
138
Up-regulation of Human Herpesvirus 6B-derived microRNAs in the Serum of Patients with Drug-induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms. 61
29542806 2018
139
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome successfully treated with mepolizumab. 61
29133221 2018
140
Comment on: Cytomegalovirus (CMV) hepatitis: an uncommon complication of CMV reactivation in drug reaction with eosinophilia and systemic symptoms. 61
29799057 2018
141
Author's reply: Cytomegalovirus (CMV) hepatitis: an uncommon complication of CMV reactivation in drug reaction with eosinophilia and systemic symptoms. 61
29796687 2018
142
Classic autoimmune type 1 diabetes mellitus after a case of drug reaction with eosinophilia and systemic symptoms (DRESS). 61
29693052 2018
143
Diffuse vesiculobullous eruption with systemic findings. 61
30142738 2018
144
Drug-induced liver injury is frequently associated with severe cutaneous adverse drug reactions: experience from two Australian tertiary hospitals. 61
29316113 2018
145
[Severe skin reactions due to new medications]. 61
29568997 2018
146
HLA-A*31:01 and Oxcarbazepine-Induced DRESS in a Patient With Seizures and Complete DCX Deletion. 61
29610167 2018
147
Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update. 61
29392710 2018
148
Clinical, Viral and Genetic Characteristics of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in Shanghai, China. 61
29242946 2018
149
Drug reaction with eosinophilia and systemic symptoms syndrome induced by benznidazole. 61
29635801 2018
150
Strategies for Successful Treatment of Active Tuberculosis in the Setting of DRESS on RIPE. 61
29644252 2018
151
Dapsone-induced drug reaction with eosinophilia and systemic symptoms associated with HLA-B*13:01. 61
29512326 2018
152
Sensitivity and specificity of the lymphocyte transformation test in drug reaction with eosinophilia and systemic symptoms causality assessment. 61
29265576 2018
153
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: Case report of severe multiorgan involvement to perindopril/amlodipine combination antihypertensive. 61
29387775 2018
154
Use of antiviral medications in drug reaction with eosinophilia and systemic symptoms (DRESS): A case of infantile DRESS. 61
29334124 2018
155
Overexpression of cytotoxic proteins correlates with liver function impairment in patients with drug reaction with eosinophilia and systemic symptoms (DRESS). 61
29521632 2018
156
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Secondary to Furosemide: Case Report and Review of Literature. 61
29440628 2018
157
Drug Reaction with Eosinophilia and Systemic Symptoms Associated with Reactivation of Epstein-Barr Virus and/or Cytomegalovirus Leading to Hemophagocytic Syndrome in One of Two Patients. 61
29386835 2018
158
Cytomegalovirus (CMV) hepatitis: an uncommon complication of CMV reactivation in drug reaction with eosinophilia and systemic symptoms. 61
29568844 2018
159
C-Reactive Protein and Procalcitonin in Case Reports of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. 61
29656292 2018
160
Recent Advances in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms. 61
29744372 2018
161
A case of a drug reaction to sulfasalazine in a patient infected with HIV. 61
30568837 2018
162
Vancomycin-Induced DRESS Syndrome: An Important Concern in Orthopedic Surgery. 61
30034896 2018
163
Lamotrigine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) during primary Epstein-Barr virus (EBV) infection. 61
29367368 2018
164
HLAs: Key regulators of T-cell-mediated drug hypersensitivity. 61
29171940 2018
165
Drug-Induced Hypersensitivity Syndrome: A Clinical, Radiologic, and Histologic Mimic of Lymphoma. 61
30420928 2018
166
Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients. 61
29546073 2018
167
A Rare Presentation of Clozapine-Induced DRESS Syndrome. 61
29991947 2018
168
[Adverse cutaneous reactions to drugs]. 61
29368897 2018
169
A familial mediterranean fever flare induced by a drug reaction with eosinophilia and systemic symptoms. 61
28653374 2018
170
Drug Reaction with Eosinophilia and Systemic Symptoms: An Update and Review of Recent Literature. 61
29527023 2018
171
Lymphoproliferative Syndromes Associated with Human Herpesvirus-6A and Human Herpesvirus-6B. 61
29755712 2018
172
Tocilizumab-induced drug reaction with eosinophilia and systemic symptoms (DRESS) in a patient with rheumatoid arthritis. 61
31431974 2018
173
Case report: atypical presentation of vancomycin induced DRESS syndrome: a case report and review of the literature. 61
29282040 2017
174
Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population. 61
28885988 2017
175
Cutaneous allergic drug reactions: update on pathophysiology, diagnostic procedures and differential diagnosic. 61
28412864 2017
176
[DRESS complicated by hemophagocytic lymphohistiocytosis in an infant treated for congenital toxoplasmosis]. 61
28728858 2017
177
A retrospective study of DRESS - drug reaction with eosinophilia and systemic symptoms. 61
29432504 2017
178
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) with Teicoplanin: A Case Report. 61
28000142 2017
179
Herpes simplex virus reactivation: is it common or rare in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms? 61
29165299 2017
180
Successful treatment of community-acquired methicillin-resistant Staphylococcus aureus purulent myopericarditis. 61
29018016 2017
181
Exacerbation of allopurinol-induced drug reaction with eosinophilia and systemic symptoms by teicoplanin: A case report. 61
28556959 2017
182
Vancomycin-associated drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: masquerading under the guise of sepsis. 61
29054953 2017
183
[Severe cutaneous drug reactions in children]. 61
28932875 2017
184
[The major SCAR syndromes]. 61
29058836 2017
185
Clinical features of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a study of 25 patients in Korea. 61
28718873 2017
186
Acute Liver Failure/Injury Related to Drug Reaction With Eosinophilia and Systemic Symptoms: Outcomes and Prognostic Factors. 61
28207633 2017
187
[DRESS syndrome and agranulocytosis, a rare combination]. 61
28669649 2017
188
Allopurinol-Induced Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome: A Cause of Acalculous Cholecystitis? 61
29057181 2017
189
Hypersensitivity to antipyretics: pathogenesis, diagnosis, and management. 61
28684647 2017
190
Urine trouble: genitourinary tuberculosis and subsequent DRESS syndrome. 61
28784884 2017
191
Acute renal failure secondary to drug-related crystalluria and/or drug reaction with eosinophilia and systemic symptom syndrome in a patient with metastatic lung cancer. 61
28748902 2017
192
Drug reaction with eosinophilia and systemic symptoms related to antiretroviral treatment in human immunodeficiency virus patients. 61
30148271 2017
193
Pharmacogenomic Advances in the Prediction and Prevention of Cutaneous Idiosyncratic Drug Reactions. 61
28295240 2017
194
Tocilizumab-Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in Adult-Onset Still Disease. 61
28531906 2017
195
Neosensitization to Multiple Drugs Following Valproate-Induced Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome. 61
28845181 2017
196
Drug reaction with eosinophilia and systemic symptoms (DRESS) successfully treated with tumor necrosis factor-α inhibitor. 61
28752124 2017
197
Prediction and management of drug reaction with eosinophilia and systemic symptoms (DRESS). 61
28633581 2017
198
DRESS Syndrome: Drug Reaction With Eosinophilia and Systemic Symptoms. 61
28665896 2017
199
Acute kidney injury in allopurinol-induced DRESS syndrome: a case report of concurrent tubulointerstitial nephritis and kidney-limited necrotizing vasculitis
. 61
27900940 2017
200
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System. 61
28598363 2017
201
Incidence of cutaneous adverse drug reactions among medical inpatients of Sultanah Aminah Hospital Johor Bahru. 61
28733562 2017
202
Skeletal myositis as the sole feature of relapsing drug reaction with eosinophilia and systemic symptoms syndrome. 61
28433575 2017
203
Highly Probable Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Associated With Lenalidomide. 61
29276264 2017
204
Safety concerns associated with second-generation antipsychotic long-acting injection treatment. A systematic update. 61
28672735 2017
205
DRESS syndrome: A case of cross-reactivity with lacosamide? 61
29588957 2017
206
Two Catastrophes in One Patient: Drug Reaction with Eosinophilia and Systemic Symptoms and Toxic Shock Syndrome. 61
28721327 2017
207
Overlapping DRESS and Stevens-Johnson Syndrome: Case Report and Review of the Literature. 61
28611628 2017
208
Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study. 61
28351788 2017
209
HLA B62 as a possible risk factor for drug reaction with eosinophilia and systemic symptoms to piperacillin/tazobactam. 61
27914818 2017
210
Drug reaction with eosinophilia and systemic symptoms from ceftriaxone confirmed by positive patch test: An immunohistochemical study. 61
27923648 2017
211
Virus Reactivation in Drug Reaction with Eosinophilia and Systemic Symptoms (Dress) Results from a Strong Drug-Specific Immune Response. 61
28483323 2017
212
Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir. 61
28369189 2017
213
Probable DRESS syndrome induced by IL-1 inhibitors. 61
28494771 2017
214
Drug Reaction with Eosinophilia and Systemic Symptoms: Retrospective Analysis of 104 Cases over One Decade. 61
28397724 2017
215
Difficult clinical management of antituberculosis DRESS syndrome complicated by MRSA infection: A case report. 61
28296768 2017
216
[Correctly adDRESS the cause of hemophagocytic lymphohistiocytosis]. 61
28161232 2017
217
Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population. 61
26927288 2017
218
A new case of imatinib-induced drug reaction with eosinophilia and systemic symptoms. 61
28164890 2017
219
Reversible Vegetative State in a Child Due to Drug Reaction with Eosinophilia and Systemic Symptoms. 61
27924464 2017
220
Acute Posterior Multifocal Placoid Pigment Epitheliopathy Associated With Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome. 61
28056129 2017
221
Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management. 61
27936971 2017
222
Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by imatinib in chronic myeloid leukemia. 61
27389710 2017
223
Drug reaction with eosinophilia and systemic symptoms in metastatic basal cell carcinoma treated with vismodegib. 61
28195319 2017
224
Eosinophilic drug reactions detected by a prospective pharmacovigilance programme in a tertiary hospital. 61
27543764 2017
225
Drug-specific CD4+ T-cell immune responses are responsible for antituberculosis drug-induced maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms syndrome. 61
27373553 2017
226
[Venous thrombosis, unrecognized complication of DRESS]. 61
27522939 2017
227
[DRESS syndrome in paediatrics: Clinical case]. 61
28288233 2017
228
Angioimmunoblastic T-Cell Lymphoma Mimicking Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome). 61
28611626 2017
229
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist. 61
28138822 2017
230
Drug reaction with eosinophilia and systemic symptoms in a child on multiple antiepileptics. 61
29276875 2017
231
[A woman with fever and a rash]. 61
28954636 2017
232
Anticonvulsant hypersensitivity syndrome after phenytoin administration in an adolescent patient: a case report and review of literature. 61
28638280 2017
233
Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population. 61
29238301 2017
234
Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians. 61
27913699 2017
235
Treatments for Severe Cutaneous Adverse Reactions. 61
29445753 2017
236
Drug reaction with eosinophilia and systemic symptoms (DRESS) and its relation with autoimmunity in a reference center in Mexico. 61
28225953 2017
237
Epidemiology of cutaneous adverse drug reactions. 61
30402608 2017
238
Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions. 61
29226159 2017
239
Tolerated drugs in subjects with severe cutaneous adverse reactions (SCARs) induced by anticonvulsants and review of the literature. 61
29026345 2017
240
How to identify DRESS, drug reaction with eosinophilia and systemic symptoms? 61
29199808 2017
241
Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome in Children: A Case Report. 61
28398207 2017
242
A Mysterious DRESS Case: Autoimmune Enteropathy Associated with DRESS Syndrome. 61
29333302 2017
243
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome associated with cefotaxime and clindamycin use in a 6 year-old boy: a case report. 61
29629004 2017
244
New Insights into Drug Reaction with Eosinophilia and Systemic Symptoms Pathophysiology. 61
29255708 2017
245
Raltegravir-induced drug reaction with eosinophilia and systemic symptoms syndrome in a child. 61
28073704 2016
246
Comparative histological analysis of drug-induced maculopapular exanthema and DRESS. 61
27422093 2016
247
Co-existence of histopathological features is characteristic in drug reaction with eosinophilia and systemic symptoms and correlates with high grades of cutaneous abnormalities. 61
27225695 2016
248
Overlap between maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms among cutaneous adverse drug reactions in a dermatology ward. 61
27128886 2016
249
Risk assessment of drug-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a disproportionality analysis using the French Pharmacovigilance Database. 61
27060861 2016
250
Drug Reaction with Eosinophilia and Systemic Symptoms or Herpes Virus Infection: Author's Reply. 61
27882668 2016
251
Febuxostat hypersensitivity: another cause of DRESS syndrome in chronic kidney disease? 61
27852432 2016
252
Cyclosporine Treatment of Drug-Induced Hypersensitivity Syndrome. 61
27438540 2016
253
The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions. 61
27368159 2016
254
Histopathological study of six types of adverse cutaneous drug reactions using granulysin expression. 61
27421110 2016
255
Koebnerization of Hailey-Hailey disease into a cutaneous drug eruption of acute generalized exanthematous pustulosis associated with systemic symptoms. 61
27433827 2016
256
Safety, tolerability, efficacy and pharmacodynamics of the selective JAK1 inhibitor GSK2586184 in patients with systemic lupus erythematosus. 61
27055521 2016
257
Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms. 61
27087170 2016
258
In vitro test to confirm diagnosis of allopurinol-induced severe cutaneous adverse reactions. 61
27106261 2016
259
A Comparative Analysis Between Antibiotic- and Nonantibiotic-Associated Delayed Cutaneous Adverse Drug Reactions. 61
27283055 2016
260
Acute Hepatitis in the DRESS Syndrome. 61
28868484 2016
261
Sulthiame-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. 61
27524391 2016
262
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand. 61
27134114 2016
263
DRESS syndrome and acute generalized exanthematous pustulosis induced by antituberculosis medications and moxifloxacin: case report
. 61
27443659 2016
264
Unusual Endoscopic Features in a Child With Drug Reaction With Eosinophilia and Systemic Symptoms. 61
25493343 2016
265
Drug Reaction With Eosinophilia and Systemic Symptoms Induced by Valproic Acid: A Case Report. 61
28144463 2016
266
Drug Reaction with Eosinophilia and Systemic Symptoms or Virus Reactivation with Eosinophilia and Systemic Symptoms. 61
27595878 2016
267
Probable Griseofulvin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms in a Child. 61
27397873 2016
268
Two cases of overlap severe cutaneous adverse reactions to benznidazole treatment for asymptomatic Chagas disease in a nonendemic country. 61
26851874 2016
269
Enigma: infection or allergy? Vancomycin-induced DRESS syndrome with dialysis-dependent renal failure and cardiac arrest. 61
27571915 2016
270
Preferential expression of CD134, an HHV-6 cellular receptor, on CD4T cells in drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS). 61
27174092 2016
271
Severe Agranulocytosis in Two Patients with Drug-induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms. 61
27025798 2016
272
DRESS Syndrome Caused by Cross-reactivity Between Vancomycin and Subsequent Teicoplanin Administration: A Case Report. 61
27572807 2016
273
Griseofulvin associated with drug reaction with eosinophilia and systemic symptoms (DRESS). 61
27556061 2016
274
Impact of the HLA-B(*)58:01 Allele and Renal Impairment on Allopurinol-Induced Cutaneous Adverse Reactions. 61
26996548 2016
275
Severe cutaneous adverse drug reactions. 61
27154258 2016
276
Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome. 61
27078005 2016
277
Histopathology of the Exanthema in DRESS Is Not Specific but May Indicate Severity of Systemic Involvement. 61
26630685 2016
278
[Human herpes virus 6 infection in an inmunocompetent patient with carbamazepine-induced DRESS syndrome]. 61
27598287 2016
279
Peripheral blood mononuclear cell gene expression testing and the heterogeneity of T-cell-mediated drug reaction with eosinophilia and systemic symptoms syndrome. 61
27067458 2016
280
Drug reaction with eosinophilia and systemic symptoms due to lercanidipine. 61
27088943 2016
281
DRESS syndrome in ophthalmic patients. 61
27463633 2016
282
Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome). 61
27310545 2016
283
Fulminating Course of Drug Reaction with Eosinophilia and Systemic Symptoms exacerbated by a Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis overlap. 61
27430091 2016
284
A 45-year-old man with shortness of breath and eosinophilia. 61
27178895 2016
285
[Drug reaction with eosinophilia and systemic symptoms]. 61
27197323 2016
286
Adverse cutaneous drug reactions in a single quaternary referral hospital. 61
26710962 2016
287
The Role and Immunobiology of Eosinophils in the Respiratory System: a Comprehensive Review. 61
26797962 2016
288
Systemic hypersensitivity reaction to Omnipaque radiocontrast medium: a case of mini-DRESS. 61
27099722 2016
289
Eosinophilic Drug Allergy. 61
26006718 2016
290
Pompholyx as a clinical manifestation suggesting increased serum IgG levels in a patient with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. 61
26412450 2016
291
Drug Reaction with Eosinophilia and Systemic Symptoms in Children: A Prospective Study. 61
27001334 2016
292
Drug reaction with eosinophilia and systemic symptoms: a clinicopathological study of six cases at a teaching hospital in midwestern Brazil. 61
26329991 2016
293
Adult with morbilliform rash and tattoo bullae. 61
27136636 2016
294
DRESS syndrome potentially induced by allopurinol and triggered by influenza vaccine. 61
27030460 2016
295
Alopecia Areata and Vitiligo as a Long-term Sequelae of Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome. 61
27057057 2016
296
Severe adverse drug reactions. 61
26833523 2016
297
Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Induced by Levetiracetam in a Pediatric Patient. 61
26597350 2016
298
Profile of vemurafenib-induced severe skin toxicities. 61
26524690 2016
299
Serological evidence that activation of ubiquitous human herpesvirus-6 (HHV-6) plays a role in chronic idiopathic/spontaneous urticaria (CIU). 61
26361716 2016
300
Anesthetic Management of a Patient with DRESS Syndrome for Renal Transplantation. 61
28078063 2016
301
Drug reaction with eosinophilia and systemic symptoms (DRESS): A histopathology based analysis. 61
26728807 2016
302
Rivaroxaban-Induced Drug Reaction With Eosinophilia and Systemic Symptoms. 61
27164633 2016
303
Systemic Toxicity of Intraperitoneal Vancomycin. 61
27840751 2016
304
DRESS Syndrome in the ICU: When a Patient Is Treated with Multiple Drugs. 61
26904309 2016
305
Drug reaction with eosinophilia and systemic symptoms syndrome associated with Nitrofurantoin. 61
26985439 2016
306
HLA-B (*) 58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand. 61
27486401 2016
307
Severe Cutaneous Drug Reactions: Do Overlapping Forms Exist? 61
26520037 2016
308
Severe delayed skin reactions related to drugs in the paediatric age group: A review of the subject by way of three cases (Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS). 61
26089185 2016
309
Adverse cutaneous drug eruptions: current understanding. 61
26553194 2016
310
Severe Drug Hypersensitivity Reactions: Clinical Pattern, Diagnosis, Etiology and Therapeutic Options. 61
27779083 2016
311
[Allopurinol-induced DRESS complicated by hemophagocytic lymphohistiocytosis]. 61
25982828 2015
312
Febuxostat-associated drug reaction with eosinophilia and systemic symptoms (DRESS). 61
26365588 2015
313
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A National Analysis of Data from 10-Year Post-marketing Surveillance. 61
26370105 2015
314
Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients. 61
26271788 2015
315
Drug reaction with eosinophilia and systemic symptoms syndrome. 61
26534757 2015
316
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases. 61
26354734 2015
317
Lamotrigine induced DIHS/DRESS: Manifestations, treatment, and outcome in 57 patients. 61
26209753 2015
318
Drug reaction with eosinophilia and systemic symptoms without skin rash. 61
26729967 2015
319
Drug Reaction, Eosinophilia and Systemic Symptoms (DRESS) syndrome secondary to allopurinol with early lymphadenopathy and symptom relapse. 61
26438678 2015
320
DRESS syndrome: cerebral vasculitic-like presentation. 61
26210912 2015
321
[DRUG INDUCED EXANTHEMA AND SEVERE CUTANEOUS DRUG REACTIONS]. 61
26619740 2015
322
US Food and Drug Administration warning about the risk of drug reaction with eosinophilia and systemic symptoms with ziprasidone. 61
26455682 2015
323
DRESS syndrome due to antibiotic therapy of osteoarticular infections in children: two case reports. 61
25052739 2015
324
Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions. 61
25946710 2015
325
Monitoring the acute response in severe hypersensitivity reactions to drugs. 61
26110678 2015
326
New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity. 61
26254052 2015
327
Severe drug-induced skin reactions: clinical features, diagnosis, etiology, and therapy. 61
26110722 2015
328
Research on Susceptible Genes and Immunological Pathogenesis of Cutaneous Adverse Drug Reactions in Chinese Hans. 61
26067314 2015
329
Antiepileptic drugs and adverse skin reactions: An update. 61
25933949 2015
330
Dapsone hypersensitivity syndrome in a lepromatous leprosy patient--A Case Report. 61
26502691 2015
331
Erythema multiforme-like drug reaction with eosinophilia and systemic symptoms (DRESS). 61
25545118 2015
332
Liver injury in patients with DRESS: A clinical study of 72 cases. 61
25801338 2015
333
Lamotrigine-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). 61
26055594 2015
334
[DRESS syndrome: Report of nine cases]. 61
26203568 2015
335
Two cases with HSS/DRESS syndrome developing after prosthetic joint surgery: does vancomycin-laden bone cement play a role in this syndrome? 61
26021379 2015
336
[Interstitial nephritis in rheumatic diseases]. 61
25962450 2015
337
Recurrence of drug-induced reactions in DRESS patients. 61
24628777 2015
338
Adverse cutaneous drug reactions--a clinico-demographic study in a tertiary care teaching hospital of the Kashmir Valley, India. 61
25841943 2015
339
Recent advances of pharmacogenomics in severe cutaneous adverse reactions: immune and nonimmune mechanisms. 61
25938070 2015
340
[Cutaneous adverse drug reactions]. 61
25458866 2015
341
Association of CD8(+) T lymphocyte repertoire spreading with the severity of DRESS syndrome. 61
25905582 2015
342
Post-traumatic stress disorder following drug reaction with eosinophilia and systemic symptoms. 61
25154661 2015
343
Drug reaction with eosinophilia and systemic symptoms syndrome probably induced by a lamotrigine-ginseng drug interaction. 61
25756365 2015
344
Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR). 61
25623158 2015
345
Drug reaction with eosinophilia and systemic symptoms during primary Epstein-Barr virus infection. 61
25074626 2015
346
Therapeutic management of DRESS: a retrospective study of 38 cases. 61
25592341 2015
347
Drug reaction with eosinophilia and systemic symptoms syndrome is not uncommon and shows better clinical outcome than generally recognised. 61
24388810 2015
348
Drug reaction with eosinophilia and systemic symptoms: manifestations, treatment, and outcome in 17 patients. 61
24738653 2015
349
Severe cutaneous adverse reaction to telaprevir. 61
25612120 2015
350
Differential expression profile of Th1/Th2-associated chemokines characterizes Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) as distinct entities. 61
25547780 2015
351
Severe cutaneous adverse drug reactions: a clinicoepidemiological study. 61
25657416 2015
352
DRESS syndrome as a complication of treatment of hepatitis C virus-associated post-inflammatory liver cirrhosis with peginterferon α2a and ribavirin. 61
25610356 2014
353
The serum level of HMGB1 (high mobility group box 1 protein) is preferentially high in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. 61
24903194 2014
354
Evidence for human herpesvirus-6B infection of regulatory T-cells in acute systemic lymphadenitis in an immunocompetent adult with the drug reaction with eosinophilia and systemic symptoms syndrome: a case report. 61
25249343 2014
355
Severe cutaneous adverse reactions in a local hospital setting: a 5-year retrospective study. 61
25070588 2014
356
Drug reaction with eosinophilia and systemic symptoms syndrome (DRESS) syndrome associated with azithromycin presenting like septic shock: a case report. 61
25297051 2014
357
Drug reaction with eosinophilia and systemic symptoms, or virus reactivation with eosinophilia and systemic symptoms as a manifestation of immune reconstitution inflammatory syndrome in a patient with HIV? 61
24773172 2014
358
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with histologic features mimicking cutaneous pseudolymphoma. 61
25156337 2014
359
Suspicion of fenofibrate-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report. 61
25269143 2014
360
Severe cutaneous reactions to drugs in the setting of a general hospital. 61
25184915 2014
361
Severe enterocolitis associated with antiepileptic-induced drug reaction with eosinophilia and systemic symptoms. 61
24935058 2014
362
A case of DRESS (drug reaction with eosinophilia and systemic symptoms) with acute interstitial nephritis secondary to lenalidomide. 61
23999760 2014
363
Recommendations for the management of beta-lactam intolerance. 61
23549754 2014
364
Management of nonimmediate hypersensitivity reactions to drugs. 61
25017673 2014
365
Elevated serum thymus and activation-regulated chemokine (TARC/CCL17) relates to reactivation of human herpesvirus 6 in drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS). 61
24601914 2014
366
Vancomycin-associated drug reaction with eosinophilia and systemic symptoms syndrome. 61
25041771 2014
367
Histopathologic spectrum of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): a diagnosis that needs clinico-pathological correlation. 61
24819756 2014
368
HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis. 61
24322785 2014
369
Skin testing and patch testing in non-IgE-mediated drug allergy. 61
24740692 2014
370
TNF-α as a useful predictor of human herpesvirus-6 reactivation and indicator of the disease process in drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS). 61
24517870 2014
371
Omeprazole-induced drug reaction with eosinophilia and systemic symptoms (DRESS). 61
24751668 2014
372
Comparison of diagnostic criteria and determination of prognostic factors for drug reaction with eosinophilia and systemic symptoms syndrome. 61
24843796 2014
373
Tc1 clonal T cell expansion during chronic graft-versus-host disease-associated hypereosinophilia. 61
24468638 2014
374
Extensive pulmonary involvement with raltegravir-induced DRESS syndrome in a postpartum woman with HIV. 61
24798353 2014
375
Drug reaction with eosinophilia and systemic symptoms: observations from a tertiary care institution. 61
24823399 2014
376
Presence of the HLA-A*3101 allele in a familial case of drug reaction with eosinophilia and systemic symptoms, secondary to carbamazepine. 61
24635066 2014
377
Epidemiology of cutaneous drug-induced reactions. 61
24819642 2014
378
Pharmacogenetic markers of severe cutaneous adverse drug reactions. 61
24819643 2014
379
Toxocarosis and putative DRESS syndrome in an oncological patient: a case report. 61
24249317 2014
380
Drug reaction with eosinophilia and systemic symptoms associated with raltegravir use: case report and review of the literature. 61
24685746 2014
381
Drug reaction with eosinophilia and systemic symptoms syndrome caused by an everolimus-eluting stent. 61
23967898 2014
382
Histopathological analysis and clinical correlation of drug reaction with eosinophilia and systemic symptoms (DRESS). 61
24329105 2014
383
Comparison of cytokine gene polymorphism in drug-induced maculopapular eruption, urticaria and drug reaction with eosinophilia and systemic symptoms (DRESS). 61
23461376 2014
384
Encephalopathy and strokes secondary to drug reaction with eosinophilia and systemic symptoms: a case report. 61
24607054 2014
385
Stevens-Johnson syndrome and toxic epidermal necrolysis: clinical patterns, diagnostic considerations, etiology, and therapeutic management. 61
25037254 2014
386
Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome. 61
23866082 2014
387
Fever, eosinophilia, and death: a case of minocycline hypersensitivity. 61
24605348 2014
388
Prolonged evolution of drug reaction with eosinophilia and systemic symptoms: clinical, virologic, and biological features. 61
24369386 2014
389
Drug Reaction with Eosinophilia and Systemic Symptoms: DRESS following Initiation of Oxcarbazepine with Elevated Human Herpesvirus-6 Titer. 61
24826354 2014
390
DRESS syndrome. 61
23816504 2014
391
Clinical and laboratory improvement after intravenous immunoglobulin in drug reaction with eosinophilia and systemic symptoms. 61
24565781 2014
392
Retinal hemorrhages and intermediate uveitis in a patient with drug reaction with eosinophilia and systemic symptoms syndrome: a case report. 61
25372334 2014
393
HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review. 61
24901010 2014
394
Chronic Hepatitis C Therapy in Liver Cirrhosis Complicated by Telaprevir-Induced DRESS. 61
25214847 2014
395
DRESS syndrome with hepatic involvement in a patient with depressive disorder. 61
25509560 2014
396
Piperacillin-induced DRESS: distinguishing features observed in a clinical and allergy study of 8 patients. 61
25668894 2014
397
Direct-acting antiviral-associated dermatitis during chronic hepatitis C virus treatment. 61
23775427 2013
398
Herpesviruses and the microbiome. 61
23611298 2013
399
Drug reaction with eosinophilia and systemic symptoms syndrome associated with antituberculosis medications. 61
24569311 2013
400
Reply to: "Using a diagnostic score when reporting the long-term sequelae of the drug reaction with eosinophilia and systemic symptoms". 61
24238172 2013
401
Drug reaction with eosinophilia and systemic symptoms syndrome: a picture is worth a thousand words. 61
24238166 2013
402
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome and dysphagia: a noteworthy association. 61
24238169 2013
403
Drug reaction with eosinophilia and systemic symptoms syndrome and toxic epidermal necrolysis: an uncommon confounding oral mucosal overlap. 61
24238167 2013
404
Using a diagnostic score when reporting the long-term sequelae of the drug reaction with eosinophilia and systemic symptoms syndrome. 61
24238171 2013
405
Diagnosis of DRESS (drug reaction with eosinophilia and systemic symptoms) in the intensive care unit: essential but challenging. 61
24135666 2013
406
Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. 61
23855313 2013
407
Fever and exanthema in a young patient: drug reaction with eosinophilia and systemic symptoms due to allopurinol. 61
23726774 2013
408
Shock state: an unrecognized and underestimated presentation of drug reaction with eosinophilia and systemic symptoms. 61
24088996 2013
409
A case of drug reaction with eosinophilia and systemic symptoms induced by ethambutol with early features resembling Stevens-Johnson syndrome. 61
23584150 2013
410
Drug reaction with eosinophilia and systemic symptoms and thyroiditis: human herpesvirus-6, the possible common link. 61
23725057 2013
411
DRESS syndrome in a child treated for toxoplasma retinochoroiditis. 61
24054036 2013
412
Characteristics of liver injury in drug-induced systemic hypersensitivity reactions. 61
23632341 2013
413
Raltegravir-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome - implications for clinical practice and patient safety. 61
23970584 2013
414
[Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): a review]. 61
23954978 2013
415
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome secondary to antituberculosis drugs and associated with human herpes virus-7 (HHV-7). 61
23904426 2013
416
Ceftazidime-induced drug reaction with eosinophilia and systemic symptoms (DRESS) complicated by hemophagocytic lymphohistiocytosis. 61
24565550 2013
417
Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) in an Adolescent Treated With Lamotrigine. 61
24052787 2013
418
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. 61
23882307 2013
419
Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution. 61
23182063 2013
420
DRESS syndrome: Part I. Clinical perspectives. 61
23602182 2013
421
Thyroid dysfunction in drug reaction with eosinophilia and systemic symptoms (DRESS): an unusual manifestation of systemic drug hypersensitivity. 61
23614562 2013
422
Fulminant type 1 diabetes in the course of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome. 61
23613608 2013
423
Saliva polymerase chain reaction assay for detection and follow-up of herpesvirus reactivation in patients with drug reaction with eosinophilia and systemic symptoms (DRESS). 61
23426332 2013
424
DRESS syndrome: Part II. Management and therapeutics. 61
23602183 2013
425
[DRESS syndrome. A clinical case report]. 61
23883465 2013
426
Drug reaction with eosinophilia and systemic symptoms syndrome associated myocarditis: a survival experience after extracorporeal membrane oxygenation support. 61
23173909 2013
427
[Severe delayed drug hypersensitivity reactions]. 61
23667969 2013
428
Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan. 61
22959230 2013
429
Drug rash with eosinophilia and systemic symptoms syndrome associated with use of phenytoin, divalproex sodium, and phenobarbital. 61
23456403 2013
430
A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. 61
23136927 2013
431
A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions. 61
22211830 2013
432
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): an atypical case during treatment with sulfasalazine. 61
23406887 2013
433
Severe DRESS syndrome managed with therapeutic plasma exchange. 61
23420918 2013
434
Pustular-type drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to carbamazepine with systemic muscle involvement. 61
23216243 2013
435
Lack of liver uptake of 99mTc leukocyte scan in the setting of alcoholic steatohepatitis and dress syndrome. 61
23334132 2013
436
Atypical erythema multiforme is a prognostic indicator of severe hepatic dysfunction in Dress (Drug Reaction with Eosinophilia and Systemic Symptoms). 61
23362966 2013
437
Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases. 61
23034060 2013
438
Telaprevir-related dermatitis. 61
23560295 2013
439
Clinical features and prognostic factors in severe cutaneous drug reactions. 61
24193402 2013
440
Phenytoin induced life threatening macroglossia in a child. 61
23546362 2013
441
Phenytoin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report from the emergency department. 61
21852061 2013
442
Successful Treatment of Antiepileptic Drug-Induced DRESS Syndrome with Pulse Methylprednisolone. 61
23691411 2013
443
Drug reaction with eosinophilia and systemic symptoms syndrome in a patient taking phenytoin and levetiracetam: a case report. 61
23286229 2013
444
DRESS syndrome following ciprofloxacin exposure: An unusual association. 61
24340128 2013
445
Amikacin-induced drug reaction with eosinophilia and systemic symptoms syndrome: delayed skin test and ELISPOT assay results allow the identification of the culprit drug. 61
22840850 2012
446
Drug reaction with eosinophilia and systemic symptoms (DRESS) in a patient taking sitagliptin. 61
23183246 2012
447
Drug Reaction with Eosinophilia and Systemic Symptoms: an update on pathogenesis. 61
23062470 2012
448
Drug reaction with eosinophilia and systemic symptoms associated with H1N1 vaccination. 61
23253004 2012
449
[Drug reaction with eosinophilia and systemic symptoms (DRESS)]. 61
23424909 2012
450
Drug reaction with eosinophilia and systemic symptoms caused by lenalidomide. 61
23137713 2012
451
Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity. 61
22850190 2012
452
Raltegravir-induced DRESS syndrome. 61
22803794 2012
453
Hepatic necrosis associated with drug-induced hypersensitivity syndrome. 61
31528583 2012
454
Drug reaction with eosinophilia and systemic symptoms (DRESS): a complex interaction of drugs, viruses and the immune system. 61
23101424 2012
455
Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist? 61
23009177 2012
456
Enoxaparin-Induced DRESS Syndrome. 61
23185158 2012
457
DRESS: clinicopathological features of 10 cases from an University Hospital in São Paulo. 61
23044561 2012
458
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms syndrome induced by cilostazol and carbamazepine. 61
22380544 2012
459
HLA and pharmacogenetics of drug hypersensitivity. 61
22920398 2012
460
Treatment of DIHS/DRESS syndrome with combined N-acetylcysteine, prednisone and valganciclovir--a hypothesis. 61
22739739 2012
461
Levetiracetam-induced drug reaction with eosinophilia and systemic symptoms syndrome. 61
22764327 2012
462
Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature. 61
22283782 2012
463
Drug reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome (DIHS): a review of current concepts. 61
22714760 2012
464
The association between DRESS and the diminished numbers of peripheral B lymphocytes and natural killer cells. 61
22432939 2012
465
Six-year retrospective review of drug reaction with eosinophilia and systemic symptoms. 61
22002792 2012
466
Severe hypocalcemia and drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome under deferasirox therapy for myelodysplasic syndrome. 61
22120845 2012
467
Is drug allergy less prevalent than previously assumed? A 5-year analysis. 61
21916887 2012
468
Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect? 61
21792562 2012
469
[Six cases of spring DRESS]. 61
22225738 2012
470
Alternative procedure to allow continuation of dapsone therapy despite serious adverse reaction in a case of dapsone-sensitive erythema elevatum diutinum. 61
22508198 2012
471
A case of drug reaction with eosinophilia and systemic symptoms. 61
22966234 2012
472
Erythema multiforme vs. DRESS syndrome associated with the combined use of lamotrigine and cyclobenzaprine: a case report. 61
23885514 2012
473
Epidemiology of cutaneous adverse drug reactions. 61
22613850 2012
474
Iatrogenic skin injury in hospitalized patients. 61
22014984 2011
475
Drug reaction with eosinophilia and systemic symptoms (DRESS) associated with azithromycin in acute Epstein-Barr virus infection. 61
22010986 2011
476
DRESS with delayed onset acute interstitial nephritis and profound refractory eosinophilia secondary to Vancomycin. 61
21968185 2011
477
Mercury as a cause of fulminant hepatic failure in a child: case report and literature review. 61
21820988 2011
478
Pediatric dermatology emergencies. 61
21670682 2011
479
DRESS syndrome associated with raltegravir. 61
21906494 2011
480
[Auto-immune thyroiditis and drug reaction with eosinophilia and systemic symptoms (DRESS) associated with HHV-6 viral reactivation]. 61
21893231 2011
481
Ramipril-induced drug reaction with eosinophilia and systemic symptoms (DRESS). 61
21697047 2011
482
Drug reaction with eosinophilia and systemic symptoms and severe involvement of digestive tract: description of two cases. 61
21410659 2011
483
Drug reaction with eosinophilia and systemic symptoms induced by carbamazepine: DRESSed to kill. 61
21762844 2011
484
Phenotype standardization for immune-mediated drug-induced skin injury. 61
21562486 2011
485
Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by cidofovir in a transplant recipient: a misunderstanding of DRESS. 61
21501355 2011
486
Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs. 61
21359537 2011
487
Ten cases of drug reaction with eosinophilia and systemic symptoms (DRESS) treated with pulsed intravenous methylprednisolone. 61
21527371 2011
488
Drug hypersensitivity: pharmacogenetics and clinical syndromes. 61
21354501 2011
489
[Strontium ranelate-induced DRESS syndrome]. 61
21333824 2011
490
Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking. 61
21143513 2011
491
DRESS syndrome with mild manifestations as a diagnostic and therapeutic problem: case report. 61
21830461 2010
492
Penicillin V-induced drug rash with eosinophilia and systemic symptoms. 61
21702250 2010
493
Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. 61
20713773 2010
494
Tolerance and safety of nifurtimox in patients with chronic chagas disease. 61
20932171 2010
495
[Management of drug reaction with eosinophilia and systemic symptoms (DRESS)]. 61
21074653 2010
496
Allopurinol-induced drug reaction with eosinophilia and systemic symptoms syndrome with recurrence. 61
20929487 2010
497
Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. 61
20739682 2010
498
Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia. 61
20618508 2010
499
Severe exfoliative dermatitis caused by strontium ranelate: two cases of a new drug reaction. 61
20299323 2010
500
Bosentan-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. 61
20439535 2010
501
Drug reaction with eosinophilia and systemic symptoms. 61
19933788 2010
502
Cyclophosphamide therapy for corticoresistant drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a patient with severe kidney and eye involvement and Epstein-Barr virus reactivation. 61
20110143 2010
503
Minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome with persistent myocarditis. 61
19665822 2010
504
[DRESS syndrome as a result of sulfasalazine use]. 61
23134745 2010
505
Minocycline in acne vulgaris: benefits and risks. 61
20642295 2010
506
Amoxicillin-induced flare in patients with DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms): report of seven cases and demonstration of a direct effect of amoxicillin on Human Herpesvirus 6 replication in vitro. 61
19822481 2010
507
A case of psoriasis worsened by atorvastatin. 61
21886735 2009
508
Drug reaction with eosinophilia and systemic symptoms: a cause of human herpesvirus 6-related fulminant myocarditis and hepatitis in immunocompetent patients. 61
19762069 2009
509
Results of treatment of acute liver failure patients with use of the prometheus FPSA system. 61
19857681 2009
510
[Drug patch tests in the investigation of cutaneous adverse drug reactions]. 61
19686903 2009
511
Drug hypersensitivity syndrome induced by meglumine antimoniate. 61
19478253 2009
512
Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy. 61
19371237 2009
513
Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease. 61
19103366 2009
514
[Atorvastatin-induced drug reaction with eosinophilia and systemic symptoms (DRESS)]. 61
19171231 2009
515
Persistent high nevirapine blood level with DRESS syndrome 12 days after interruption of antiretroviral therapy. 61
21686791 2009
516
Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. 61
19153346 2009
517
Oxcarbazepine-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). 61
18821094 2008
518
An unusual case of DRESS syndrome. 61
21886711 2008
519
Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms syndrome in a 35-year-old man with epilepsy. 61
18836349 2008
520
Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review. 61
18717872 2008
521
Acute renal failure in a 3-year-old child as part of the drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome following hepatitis A. 61
18040726 2008
522
DRESS syndrome caused by efalizumab. 61
18021270 2008
523
Drug-induced skin, nail and hair disorders. 61
17973540 2007
524
Epidemiological study of severe cutaneous adverse drug reactions in a city district of China. 61
16901302 2006
525
[Drug reaction with eosinophilia and systemic symptoms (DRESS) following imatinib therapy]. 61
17053739 2006
526
[DRESS syndrome related to Hexaquine (quinine and thiamine)]. 61
16733450 2006
527
[Hypersensitivity to fluindione (Previscan). Positive skin patch tests]. 61
16446646 2005
528
Clinical heterogeneity of drug hypersensitivity. 61
15767024 2005
529
[Study of the clonality of cutaneous and blood lymphocytes during drug-induced hypersensitivity in 6 patients]. 61
15692439 2004
530
Severe sialadenitis: a new complication of drug reaction with eosinophilia and systemic symptoms. 61
15523370 2004
531
[Drug hypersensitivity syndrome: DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms)]. 61
15107755 2004
532
DRESS syndrome associated with HHV-6 reactivation. 61
14962704 2003
533
Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. 61
12165215 2002
534
Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. 61
11255328 2001

Variations for Drug Reaction with Eosinophilia and Systemic Symptoms

Expression for Drug Reaction with Eosinophilia and Systemic Symptoms

Search GEO for disease gene expression data for Drug Reaction with Eosinophilia and Systemic Symptoms.

Pathways for Drug Reaction with Eosinophilia and Systemic Symptoms

Pathways related to Drug Reaction with Eosinophilia and Systemic Symptoms according to GeneCards Suite gene sharing:

(showing 3, show less)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
11.02 TNFRSF4 TNF
2
Show member pathways
10.74 TNFRSF4 TNF
3 9.9 TNF CRP

GO Terms for Drug Reaction with Eosinophilia and Systemic Symptoms

Cellular components related to Drug Reaction with Eosinophilia and Systemic Symptoms according to GeneCards Suite gene sharing:

(showing 2, show less)
# Name GO ID Score Top Affiliating Genes
1 cell surface GO:0009986 9.13 TNFRSF4 TNF HLA-B
2 external side of plasma membrane GO:0009897 8.8 TNFRSF4 TNF HLA-B

Biological processes related to Drug Reaction with Eosinophilia and Systemic Symptoms according to GeneCards Suite gene sharing:

(showing 5, show less)
# Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.33 TNFRSF4 TNF HLA-B
2 tumor necrosis factor-mediated signaling pathway GO:0033209 9.32 TNFRSF4 TNF
3 defense response to Gram-positive bacterium GO:0050830 9.26 TNF CRP
4 inflammatory response GO:0006954 9.13 TNFRSF4 TNF CRP
5 negative regulation of lipid storage GO:0010888 8.62 TNF CRP

Sources for Drug Reaction with Eosinophilia and Systemic Symptoms

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....